See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
iShares Dow Jones US Pharmaceuticals (IHE)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Comments
News & PR
Market Currents
Buzz
Twitter: IHE
Coverage
Top Authors
Cramer
Top Analysts
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
ETF Stats for IHE
Expense Ratio:
0.48%
Average Bid Ask Ratio:
0.08%
Tracking Error:
0.17%
Concentration Risk:
17.50%
Capital Gains Dist. %:
0.00%
Number of Securities:
30
Dividend Amount:
$0.197006
Dividend Date:
12/23/2009
For overall rating and ranking versus other ETFs get a
free trial
to
XTF Premium
Analysis - Latest Articles
ETF Update: Investing in India
Jeff Miller
•
Dec 28
•
3 Comments
Many Reasons to Launch a Global Generic Drug ETF
Mike Havrilla
•
Dec 24
•
5 Comments
Which ETFs Were Spurned by the Health Care Bill?
Tom Lydon
•
Dec 23
•
Comment!
5 ETFs with Attractive Prices and Low Betas
Gary Gordon
•
Dec 22
•
1 Comment
ETF Update: Health Care Legislation and Its Impact on Drug Stocks
Jeff Miller
•
Dec 21
•
Comment!
Emerging Markets: The Next Big Driver of Pharmaceutical, Biotech ETFs?
Tom Lydon
•
Dec 18
•
1 Comment
More articles on IHE »
Instablogs
Health Care Plan Poses Risks for ETFs
Mon December 21, 2009
•
Don Dion
•
1 Comment
2 Reasons to Worry about the Future of America
Wed August 26, 2009
•
The Inoculated Investor
•
Comment!
ETFs a Safer Way to Bet on Health Care
Wed August 19, 2009
•
Don Dion
•
Comment!
Write a post on IHE
|
More Instablogs on IHE »
What's your view of IHE?
Make sure you include IHE
140 characters left
|
Settings